|Bid||0.0000 x 0|
|Ask||0.0000 x 0|
|Day's Range||0.3750 - 0.4440|
|52 Week Range||0.0340 - 0.6050|
|Beta (3Y Monthly)||1.69|
|PE Ratio (TTM)||N/A|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||N/A|
VANCOUVER, April 29, 2019 /PRNewswire/ - Chemistree Technology Inc. (CSE:CHM and CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that the Company has entered into a funding agreement with The Physician's Choice CBD LLC of Phoenix, Arizona. The Physician's Choice CBD ("PCCBD") is dedicated to research, development, and utilization of the highest quality of hemp-derived cannabidiol (CBD) combined with well-studied and effective supplements specific to help regulate and support various symptoms. In it's first quarter of sales ended January 2019, the company booked approximately $150,000 in sales.
VANCOUVER, April 18, 2019 /PRNewswire/ - Chemistree Technology Inc. (CSE:CHM and CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to provide shareholders with an update on the Company's Washington State assets and its Desert Hot Springs, California cultivation facility development. With the full support of Chemistree as landlord and turnkey equipment provider, this group of people continue to do a tremendous job in restoring Sugarleaf to its previous place in the Washington market for flower and pre-rolled products as well as introducing new exciting products to the market.
VANCOUVER , April 15, 2019 /CNW/ - Chemistree Technology Inc. (CHM.CN) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to announce that its wholly owned U.S. subsidiary, American CHM Investments Inc., has signed a letter of intent (LOI) to partner with Applied Cannabis Sciences of New Jersey ("ACS"), a New Jersey -based medical retail dispensary applicant in the upcoming New Jersey round of Request for Applications (RFA), which is anticipated in 2020. Applied Cannabis Sciences has been established by a team of seasoned professionals from the legal medicinal and adult use marijuana industry whose collective experience exceeds 50 years and includes over 20 cultivation, processing, and manufacturing licenses across four states ( Washington , Oregon , California , and Colorado ) within the U.S. The ACS team is predominantly made up of professionals that reside and currently operate from New Jersey and maintain multiple strategic relationships.
VANCOUVER, April 11, 2019 /PRNewswire/ - Chemistree Technology Inc. (CSE:CHM and CHM.wt) (US OTCQB: CHMJF) (the "Company" or "Chemistree"), is pleased to announce the appointment of Mr. Sheldon Aberman to the newly-created position of Chief Cannabis Officer. This addition will further strengthen its team and advance the Company's international expansion strategy, cultivation practices and results in terms of yield, quality, consistency and cost-effectiveness as it continues to execute across these areas and solidify its position as a world leader within the industry. Mr. Aberman has a well-earned reputation as one of the world's foremost experts on commercial cannabis cultivation with decades of experience managing and designing thousands of grows worldwide. His expertise, hands on approach and product development background has led to top quality grow room design and construction. Additionally, he has created several multi-million-dollar industry partnerships and other ventures, such as Quantum Horticulture, Pure Essentials Black Label and Cannabis Consulting Co. whose various products and services have been implemented, utilized and run in thousands of grows globally.
Chemistree Technology Inc. (CSE:CHM) (OTCQB: CHMJF), an investment company dedicated to the US cannabis sector endeavoring to provide turn-key solutions for the regulated cannabis industry, recently announced the addition of Nicholas J. Zitelli, a.k.a. Mr. Zitelli is a well-known cannabis industry leader.
Mr. Zitelli is currently part-owner, Director, and Chief Cannabis Officer of Trans High Corporation (THC), the parent company for all HIGH TIMES brands, including its 45-year old flagship magazine, as well as all related media and event platforms, including the iconic Cannabis Cup. Since 2007, Mr. Zitelli has authored hundreds of articles covering all aspects of cannabis science and technology under the penname of "Nico Escondido". In this capacity, Mr. Zitelli has garnered a reputation as an industry expert in the areas of cultivation, genetics, garden technologies, lab testing, and regulatory and compliance measures.
VANCOUVER , April 5, 2019 /CNW/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM and CHM.WT) (US OTCQB: CHMJF) (the "Company" or "Chemistree") pursuant to the Company's stock option plan -- has granted options to purchase 1,300,000 common shares at $0.60 per share to certain eligible directors, officers and consultants. Additionally, Chemistree has re-engaged Native Ads to provide, manage and consult on a wide variety of marketing and digital marketing initiatives for the Company.
VANCOUVER , March 29, 2019 /CNW/ - Chemistree Technology Inc. (CHM.CN) (US OTCQB: CHMJF) (the "Company" or "Chemistree") announced today that it has closed its previously announced short form prospectus offering (the "Brokered Offering") and concurrent private placement (the "Concurrent Private Placement") of 10% unsecured debenture units (the "Debenture Units") of the Company, for total gross proceeds of $10,830,000 . Concurrent with the Brokered Offering, the Company issued an aggregate of 1,400 Debenture Units at the Offering Price, for aggregate gross proceeds of $1,400,000 , on a private placement basis.
VANCOUVER , March 25, 2019 /CNW/ - Chemistree Technology Inc. (CHM.CN) (US OTCQB: CHMJF) (the "Company" or "Chemistree") announced today that it has filed and obtained a receipt for a final short form prospectus in each of the provinces of Canada , other than Québec, in connection with its previously announced offering (the "Offering") of up to 8,200 debenture units of the Company (the "Initial Units") at a price of $1,000 per Initial Unit (the "Offering Price") for aggregate gross proceeds to the Company of up to $8,200,000 . Concurrent with the Offering, the Company intends to issue up to 1,400 debenture units of the Company (the "Private Placement Units") at the Offering Price on a non-brokered private placement basis for aggregate gross proceeds of up to $1,400,000 (the "Concurrent Private Placement").
The CUP encompasses cultivation in two greenhouse buildings totaling approximately 128,000 square feet, and an additional building of up to an additional 40,000 square feet for processing, manufacturing and distribution of cannabis goods. Fully constructed, the Company expects that a facility of this size has the potential to produce approximately 50,000 pounds of dried-cannabis flower per year and, once fully licensed and constructed, will have the capacity to process, manufacture and distribute a range of cannabis-related products. Chemistree's President, Karl Kottmeier commented "I am really proud of our California team for getting this CUP from concept to award in less than seven months. The City of Desert Hot Springs has proven to be a terrific partner, and we look forward to commencing site works as soon as the permitting process allows.
VANCOUVER , Feb. 5, 2019 /CNW/ - Chemistree Technology Inc. (CHM.CN) (US OTCQB: CHMJF) (the "Company" or "Chemistree") announced today that it has filed a preliminary short form prospectus in each of the provinces of Canada , other than Québec, in connection with a "best efforts" offering (the "Offering") of debenture units of the Company (the "Initial Units") at a price of $1,000 per Initial Unit (the "Offering Price"). The number of the Initial Units to be sold pursuant to the Offering will be determined through discussions between the Company and the Agent, in the context of the market.
VANCOUVER , Feb. 1, 2019 /CNW/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree") is pleased to share details on the Company's involvement at Michael Campbell's MoneyTalks 2019 World Outlook Financial Conference, occurring February 1-2, 2019 , at the Westin Bayshore in Vancouver, BC . The 2019 Conference will feature an agenda dedicated exclusively to educating attendees about the benefits of having cannabis assets as part of their investment portfolio. On Friday, February 1 at 3:45 pm , Chemistree's President, Karl Kottmeier , will join a panel hosted and organized by MoneyTalks long-time analyst Mark Leibovit , founder of the Cannabis/Vice Newsletter, and Aaron Dunn of Keystone Financial as part of Cannabis Investing in 2019.
VANCOUVER , Dec. 11, 2018 /CNW/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree") is pleased to provide a progress report as it awaits award of the Continuous Use Permit from the City of Desert Hot Springs for its 9.55 acre property in located in the City's cannabis cultivation-friendly zone. Karl Kottmeier , Chemistree's President, commented "Our submission to the City of Desert Hot Springs is advancing through the regulatory process and our most recent update from our contractor has provided us with the good news that due to a rework of our plans by the City Engineer, we have an unexpected savings of approximately $500,000 to the project budget. Chemistree, as previously announced, plans to develop a greenhouse cultivation facility at the site that includes two separate cultivation buildings totaling 127,960 square feet and an additional 119,960-square-foot building intended for warehousing and processing facilities.
VANCOUVER, Dec. 6, 2018 /PRNewswire/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree") is pleased to announce that it has now entered into an agreement with Sugarleaf Farms to acquire the global brand and marketing rights to the Sugarleaf brand (outside of Washington State). Chemistree is now underway with establishing the Sugarleaf brand in California, initially via the strategic collaboration recently launched with the Humboldt County-based cannabis processing company (see press release dated November 27, 2018). The Company is currently focused on product development, biomass sourcing and sales and marketing planning as well as adding key people to the new Chemistree California team.
VANCOUVER, Dec. 4, 2018 /PRNewswire/ - Chemistree Technology Inc. (Canadian Securities Exchange: CHM) (US OTCQB: CHMJF) (the "Company" or "Chemistree") is pleased to announce the following significant developments as provided by its licensee partner managing the cultivation, processing and delivery to points of sale of the Sugarleaf branded suite of products. Traditionally a producer of high-quality cannabis flower products, Sugarleaf is now pleased to report that it is soon to launch its own line of cannabis oil-based products, to be dispensed in a special edition Sugarleaf branded Vapor Slide V2. The Vapor Slide V2 is a revolutionary distillate vaporizer that is the perfect hybrid between pen and dab. This is an exciting product as concentrates typically sell at a much higher price per gram than flower-based products and products similar to this account for approximately half of all cannabis sales in Washington State. This will be Sugarleaf's first product launch into the concentrates market and plans are already in place to expand the Sugarleaf brand into other products and devices before the end of Q1, 2019.
New York, New York--(Newsfile Corp. - December 3, 2018) - CannabisNewsAudio announces the Audio Press Release (APR) titled "Change in Attorney General Could Mean a Cannabis Revolution in the US," featuring Chemistree Technology, Inc. (CSE: CHM) (OTCQB: CHMJF).To hear the CannabisNewsAudio version, visit: http://cnw.fm/uR4M0To read the full editorial, visit: http://nnw.fm/77lmJThe property is capable of supporting development plans and a Conditional Use Permit application for three 68,000-square-foot cultivation and processing buildings on the site, ...